Patent classifications
A61F9/00718
Gland or duct diagnostic and treatment methods and related apparatus
A method is provided for treating a gland or duct of a patient. In a particular embodiment, an obstruction in a gland or duct and the orifice thereof can be alleviated; in another, a substance can be injected thereinto; in yet another, the gland can be aspirated. The method includes the step of inserting an elongated probe into a gland or duct via an orifice thereinto. In some embodiments the probe can have a longitudinal lumen therethrough, with at least one distal hole through the probe wall in fluid communication with the lumen. The lumen can be used in concert with a source of suction for removing debris from the gland or duct, and/or with a source of a fluid and pumping means, for injecting a substance into the gland or duct.
Medial orbicularis flap canthoplasty with orbicularisorrhaphy
A surgical ophthalmic procedure performs a medial canthoplasty of an eyelid system having the following steps: performing a medial subciliary skin incision in the medial inferior-eyelid skin, excising an ellipse of the medial inferior-eyelid skin extending medially upwardly; exposing the medial canthal tendon, creating an orbicularis flap from the inferior-lid orbicularis muscle, suturing the orbicularis flap to the medial canthal tendon, probing the lacrimal system to confirm the integrity of the canalicular system, excising the excess portion of the medial superior-eyelid skin, closing the medial canthal skin with deep fixation in the medial canthus, closing the medial suhciliary skin incision or extending the subciliary incision, making a supraciliary skin incision in the upper lid medially and performing an orbicularisorrhaphy by suturing the orbicularis of the upper lid to the orbicularis of the lid to further close the lid.
Systems and Methods For the Treatment of Eye Conditions
Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material. Wherein, when the eyelid is positioned between the energy transducer and the scleral shield, the light energy from the energy transducer and the heated energy-absorbing material of the scleral shield conductively heats a target tissue region sufficiently to melt meibum within meibomian glands located within or adjacent to the target tissue region.
System and method for eyelid stimulation
A system and method of treating hyperactivity of an eyelid closing muscle in a subject includes providing a stimulation system in the subject with the hyperactivity of the eyelid closing muscle, sensing an activity of the eyelid closing muscle, and selectively stimulating eyelid opening muscle(s) or innervating nerves, eyelid opening reflexes, or eyelid opening reflexes in non-muscular tissue, using the stimulation system, without substantially activating the eyelid closing muscle. The system and method evokes eyelid movement in the subject.
HANDHELD THERMAL THERAPY DEVICE
This invention discloses a handheld device to provide thermal therapy to tissue by contacting a surface heated with thermal energy to a patient's tissue. Thermal energy is continuously provided during operation. The handheld device comprises an assembly to provide heat operatively connected to a removable thermal energy applicator, the applicator is configured to provide different treatments, including heat application, debridement, and expression of the treated tissue or gland.
Systems and methods for the treatment of eye conditions
Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material. Wherein, when the eyelid is positioned between the energy transducer and the scleral shield, the light energy from the energy transducer and the heated energy-absorbing material of the scleral shield conductively heats a target tissue region sufficiently to melt meibum within meibomian glands located within or adjacent to the target tissue region.
MEDIAL ORBICULARIS FLAP CANTHOPLASTY WITH OBICULARISORRHAPHY
A surgical ophthalmic procedure performs a medial canthoplasty of an eyelid system having the following steps: performing a medial subcilliary skin incision in the medial inferior-eyelid skin, excising an ellipse of the medial inferior-eyelid skin extending medially upwardly; exposing the medial canthal tendon, creating an orbicularis flap from the inferior-lid orbicularis muscle, suturing the orbicularis flap to the medial canthal tendon, probing the lacrimal system to confirm the integrity of the canalicular system, excising the excess portion of the medial superior-eyelid skin, closing the medial canthal skin with deep fixation in the medial canthus, closing the medial subciliary skin incision or extending the subciliary incision, making a supraciliary skin incision in the upper lid medially and performing an orbicularisorrhapy by suturing the orbicularis of the upper lid to the orbicularis of the lid to further close the lid.
ELECTROLYTIC DEVICE FOR TREATING AN EYE DISORDER
Devices and methods are described for electrolytically, ultrasonically, or both electrolytically and ultrasonically disrupting debris on an eyelid margin. A device includes an eyelid contacting portion having at least a first electrode, a second electrode, and a power supply electrically coupled to at least one of the first and second electrodes. The eyelid contacting portion may optionally have a shelf separating an upper portion from a lower portion with electrodes on the upper and lower portions. The eyelid contacting portion may optionally include at least one channel with electrodes. The device may optionally include an ultrasonic driver. Another device includes an ultrasonic driver but no electrodes. A method contacts debris on an eyelid margin with a first electrode and contacting a surface of an eyelid with a second electrode and supplying electrical energy to one of the first or second electrodes to disrupt the debris. Another method applies ultrasonic energy to the eyelid margin to disrupt debris on the eyelid margin.
Systems and methods for the treatment of eye conditions
Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material. Wherein, when the eyelid is positioned between the energy transducer and the scleral shield, the light energy from the energy transducer and the heated energy-absorbing material of the scleral shield conductively heats a target tissue region sufficiently to melt meibum within meibomian glands located within or adjacent to the target tissue region.
SYSTEMS AND METHODS FOR THE TREATMENT OF EYE CONDITIONS
Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material. Wherein, when the eyelid is positioned between the energy transducer and the scleral shield, the light energy from the energy transducer and the heated energy-absorbing material of the scleral shield conductively heats a target tissue region sufficiently to melt meibum within meibomian glands located within or adjacent to the target tissue region.